The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …

Non-alcoholic fatty liver disease (NAFLD) is to date the most common chronic liver disease
in clinical practice and, consequently, a major health problem worldwide. It affects …

Nonalcoholic fatty liver disease (NAFLD) and alcohol-related liver disease (ALD) are the
leading causes of chronic liver disease worldwide. NAFLD and ALD share …

Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent form of chronic liver disease
that poses challenges in diagnosis and risk stratification. Non-alcoholic steatohepatitis …

Background & Aims A recent consensus document has defined metabolic dysfunction-
associated fatty liver disease (MAFLD) as hepatic steatosis together with overweight …

Abstract Background and Aims Recently metabolic dysfunction–associated fatty liver
disease (MAFLD) has been introduced and was defined as hepatic steatosis with either …

Chronic liver disease (CLD), manifested as hepatic injury, is a major cause of global
morbidity and mortality. CLD progresses to fibrosis, cirrhosis, and—ultimately …

Background Lipid accumulation product (LAP) is an index calculated by waist circumference
(WC) and triglyceride (TG), which reflects lipid toxicity. This study aims to investigate the …

The rising tide of non-alcoholic fatty liver disease (NAFLD) associated with the obesity
epidemic is a major health concern worldwide. NAFLD—specifically its more advanced form …

Background The effect of solid organ transplantation (SOT) on the severity and mortality of
coronavirus disease 2019 (COVID-19) remained controversial. There is still no consensus …